This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Medtronic Minimed, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations in Continuous Glucose Monitoring by Georgios Mallas
Introduction
Georgios Mallas is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of medical technology, particularly in the area of continuous glucose monitoring systems. His innovative work aims to enhance the accuracy and usability of glucose monitoring for individuals with diabetes.
Latest Patents
Georgios Mallas holds a patent for "Methods, systems, and devices for continuous glucose monitoring." This patent describes a continuous glucose monitoring system that utilizes electrode current (Isig) signals, Electrochemical Impedance Spectroscopy (EIS), and Vcntr values. The goal of this innovation is to optimize sensor glucose (SG) calculation, thereby reducing the need for blood glucose (BG) calibration requests from users. This advancement represents a significant step forward in diabetes management technology.
Career Highlights
Georgios Mallas is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management solutions. His work at Medtronic has allowed him to collaborate with other talented professionals in the field, contributing to the development of cutting-edge medical devices.
Collaborations
Some of his notable coworkers include Andrea Varsavsky and Peter Ajemba. Their collective expertise and teamwork have played a crucial role in advancing the innovations at Medtronic.
Conclusion
Georgios Mallas is a key figure in the development of continuous glucose monitoring systems, with a focus on improving the lives of those managing diabetes. His contributions through patents and collaboration with industry professionals highlight his commitment to innovation in medical technology.